Improving men's health: Evidence and opportunity

JAMA

Volumn 296, Issue 19, 2006, Pages 2373-2375

  Fontanarosa, Phil B ^a   Cole, Helene M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TESTOSTERONE; TOLTERODINE;

BIOLOGICAL RHYTHM; BLADDER NECK STENOSIS; CANCER SCREENING; CLINICAL TRIAL; EDITORIAL; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; WELLBEING;

EID: 33750974750     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.19.2373     Document Type: Editorial

References (23)

1. Preamble to the Constitution of the World Health Organization http://policy.who.int/cgi-bin/om_isapi.dll?hitsperheading=on&infobase= basicdoc&record={21}&softpage=Document42. Accessed October 20, 2006.
2. Fontanarosa PB, Cole HM. Theme issue on men's health: call for papers. JAMA. 2006;295:440-441.
3. Boyle P, Robertson C, Mazzetta C, et al; UrEpik Study Group. The prevalence of lower urinary tract symptoms in men and women in four centres: the UrEpik study. BJU Int. 2003;92:409-414.
4. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637-649.
5. Chapple CR. A comparison of varying alpha-blockers and other pharmacotherapy options for lower urinary tract symptoms. Rev Urol. 2005;7(suppl 4):S22-S30.
6. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology. 1997;50(6A suppl):90-96.
7. Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006;296:2319-2329.
8. American Cancer Society. What are the key statistics about prostate cancer? Cancer Reference Information. http://www.cancer.org/docroot/CRI/content/ CRI_2_4_1X_What_are_the_key_statistics_for_prostate_cancer_36.asp?rnav=cri. Accessed October 17, 2006.
9. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003;289:1414-1420.
10. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296:2336-2342.
11. Albertsen PC. PSA testing: public policy or private penchant? JAMA. 2006;296:2371-2373.
12. Thompson IM Jr, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA. 2006;296:2329-2335.
13. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731.
14. Tan RS, Salazar JA. Risks of testosterone replacement therapy in aging men. Expert Opin Drug Saf. 2004;3:599-606.
15. Marks LS, Mazer NA, Mostaghel E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA. 2006;296:2351-2361.
16. Lewis BH, Legato M, Fisch H. Medical implications of the male biological clock. JAMA. 2006;296:2369-2371.
17. Kidd SA, Eskenazi B, Wyrobek AJ. Effect of male age on semen quality and fertility: a review of the literature. Fertil Steril. 2001;75:237-248.
18. Reichenberg A, Gross R, Weiser M, et al. Advancing paternal age and autism. Arch Gen Psychiatry. 2006;63:1026-1032.
19. Malaspina D, Harlap S, Fennig S, et al. Advancing paternal age and risk of schizophrenia. Arch Gen Psychiatry. 2001;58:361-367.
20. Willcox BJ, He Q, Chen R, et al. Midlife risk factors and healthy survival in men. JAMA. 2006;296:2343-2350.
21. Makadon HJ, Mayer KH, Garofalo R. Optimizing primary care for men who have sex with men. JAMA. 2006;296:2362-2365.
22. Garfield CF, Clark-Kauffman E, Davis MM. Fatherhood as a component of men's health. JAMA. 2006;296:2365-2368.
23. The Guide to Clinical Preventive Services, 2005. Recommendations of the US Preventive Services Task Force. http://www.ahrq.gov/clinic. Accessed October 20, 2006.